Skip to main content

Primary Antibody vs. Secondary Antibody, How to Choose?

 Antibodies (or immunoglobulins) are Y-shaped glycoproteins released by the immune system to detect and bind to "foreign" substances, known as "antigens", triggering a cascade of actions to destroy these foreign invaders. Scientists would develop different antibodies for research use, which basically can be classified into primary and secondary antibodies. However, how to choose the right type of antibodies for different immunoassays in experiment procedures, such as western blotting (WB), enzyme-linked immunosorbent assays (ELISA), and immunoprecipitation (IP), is one of the most common questions for green hands in the laboratory.

 

Primary Antibody vs. Secondary Antibody

 

Antibodies could be categorized into two types based on the binding capability and experimental applications—primary antibodies and secondary antibodies.

 

The main difference between these two types of antibodies is that primary antibody binds specifically to an antigen, like a protein or a biomolecule of interest, while a secondary antibody bind to the primary antibody that has attached with a target antigen. Compared to secondary antibodies, primary antibodies are produced from different host species like animal species of rats, mice, goats, and rabbits, though they could both be produced in form of monoclonal (mAbs) or polyclonal antibodies (pAbs).

 

Selection of Antibodies

 

In laboratory research and clinical trials, choosing right antibody reagents is essential for correct results, which often means more accurate and reproducible study results and less waste on valuable samples and funds. The selection of antibodies should be based on these factors:

 

Applications

 

Primary antibodies are usually used in immunoassays to bind to the target antigen, including WB and cell staining, but a secondary antibody is not necessarily used. For instance, direct ELISA involves direct labeling, requiring the primary antibody to be directly labeled with an enzyme for enzymatic reaction and signal detection, in which secondary antibodies are not needed. The primary antibody is also applied in indirect ELISA but the enzyme is labeled on the secondary antibody and the secondary antibody bind to the primary antibody. Though with a relatively complex protocol and cross-reactivity risk, secondary antibodies are more sensitive and flexible in labeling and detection, which results in their usage in the colorimetric, chemiluminescent, and fluorescent detection of primary antibodies. Applications of secondary antibodies include flow cytometry, western blotting, and cell imaging, while primary antibodies are used in the detection of biomarkers for diabetes, cancer, Alzheimer's, and Parkinson's disease.

 

Source of Antibodies

 

The species that the primary antibody is raised from is another factor researchers should take into consideration. The host species of primary antibodies should be different from the species of the sample, in case that the secondary antibody cross-react with endogenous immunoglobulins in the sample. For example, research on mouse protein should use a primary antibody that is not produced by mouse, such as a primary antibody raised in rabbit, and the followed secondary antibody should be against the host species of the primary antibody, here using anti-rabbit IgG secondary antibody.

 

Clonality

 

As antibodies could be mAbs and pAbs, clonality is an additional characteristic to consider when researchers are choosing primary and secondary antibodies for research. MAbs only target one epitope of an antigen as they are produced from a single B-cell clone while pAbs that are produced from multiple B-cell clones of an animal can recognize multiple epitopes of an antigen.

 

Choosing monoclonal or polyclonal antibodies, which both have advantages and disadvantages, depends on experiment requirements. Monoclonal antibodies allow precision targeting due to high specificity and high reproducibility, but the higher expense and less possibility of working across different species are negative factors that can't be ignored. On the contrary, polyclonal antibodies are featured with higher affinity and the ability to detect and tolerate variations in the antigen and are widely available at a lower cost, but the risk of cross-reactivity is increased along with the presence of multiple epitopes.

Comments

Popular posts from this blog

How Haptens Differ from Antigens and Become Immunogens?

The  difference between antigens vs. haptens  is one the most concerning issues for people who are not familiar with them. As a matter of fact, antigens and haptens are similar in many ways. They are both molecules triggering immune responses and acting as antigenic agents. And they both work as immunogens and bind to antibodies although haptens in a different manner.   What distinguishes an antigen mostly from a hapten is that antigens are complete molecules spontaneously triggering immune response whereas haptens are fragmentary small molecules that are unable to elicit immune responses unless they are conjugated to a larger molecule, known as a carrier.   What are Antigens? Antigen s, including proteins, peptides, and polysaccharides, are immunogen   molecules  that can trigger immune response s or naturally bind to   immune   components . An antigen may have one or more epitopes, which are the determinants of recognition and binding to antibod...

Review: Creative Biolabs' Model-org Antibodies Fluorescently Labeling Services

Model organisms (Model-org) are non-human species, from which researchers can get insights into other organisms in biological research processes. Various model organism species such as zebrafish, flies, yeast, and rice, greatly contribute to the basic and clinical research in animal husbandry, fishery , agriculture, forestry, etc.   Investigations on model organisms can be aided by antibody labeling when samples of interest need to be detected, isolated, or purified, though the selection of a proper label can be a challenge.   To select the best antibody labeling way for our Model-org project, we then found Creative Biolabs, one of the most well-established CROs for antibody development. After a comprehensive discussion and consultancy with the scientists at Creative Biolabs, fluorescent tags were  suggested based on our research direction. Fluorescent labels are directly conjugated to the antibody of interest, indicating that we can directly detect the number of fluoresc...

Metagenomics Enhances Infectious Disease Surveillance

  Infectious lower respiratory diseases and diarrheal diseases are the leading causes of death globally . And the ongoing COVID-19 pandemic, which has contributed to 4.1 million deaths in 2019, once again is reminding the necessity of proactively identifying early signs of infectious disease outbreaks before things are getting worse. Conventional microbial diagnostics techniques would identify pathogens under specific culture conditions by serological detection of pathogen-associated antibodies or microbial genetic investigation using PCR, but these methods have been seen obvious shortcomings in pathogen coverage. It's highly required to find advanced scientific tools that are more sensitive even with a low microbial load or when targeted microorganisms are not suitable for  in vitro  culture, for which metagenomic approaches that can profile all DNA or RNA of a patient sample are increasingly catching the eyes of researchers.   How metagenomics can be used in infect...